Challenges of Antidepressant Management in Primary Care

Discussions about the potential overprescribing of antidepressants must begin with an understanding of who is doing most of the prescribing. In the U.S., primary care physicians (PCPs) write the majority of antidepressant prescriptions, with estimates suggesting that 60–80% originate from primary care rather than psychiatry (Mojtabai & Olfson, 2011; Mark et al., 2014). This prescribing pattern reflects broader trends in mental health treatment, where primary care has become the frontline for managing depression and other mood disorders.

Several factors contribute to this dynamic:

  • Limited access to psychiatrists: Many patients, especially in rural or underserved areas, face long wait times or geographic barriers to seeing a psychiatrist.
  • Overlap with medical conditions: PCPs frequently manage conditions like chronic pain, insomnia, and fatigue, for which antidepressants may be considered as part of the treatment plan.
  • Continuity of care: Patients often have longstanding relationships with their primary care providers, making them more comfortable discussing mood symptoms in this setting.
  • Psychiatric referral limitations: Many psychiatrists focus on complex or treatment-resistant cases, meaning initial treatment often falls under primary care.

Challenges and Considerations

While primary care plays a crucial role in mental health treatment, concerns exist regarding the effectiveness of antidepressant management in this setting:

  • Suboptimal dosing and medication selection: Studies suggest that antidepressants prescribed in primary care settings may be dosed too low or not adequately adjusted, potentially leading to partial response or treatment failure (Carrasco & Sandner, 2005). Additionally, there is a higher likelihood of using older antidepressants, which may have a less favorable side effect profile.
  • Lack of therapy integration: Guidelines recommend a combination of medication and psychotherapy for moderate-to-severe depression (APA, 2010), yet PCPs may have limited time, training, or referral resources to ensure therapy is included.
  • Potential misdiagnosis: Depressive symptoms can overlap with other psychiatric and medical conditions, leading to misdiagnosis or inappropriate treatment. For example, bipolar disorder is often misdiagnosed as major depressive disorder in primary care, which can result in inadequate treatment and risk of mood destabilization (Hirschfeld et al., 2003).

Addressing These Challenges

Several strategies can improve antidepressant management within primary care settings:

  • Collaborative care models: Studies show that integrating mental health professionals within primary care teams leads to improved outcomes, including higher remission rates and better adherence (Archer et al., 2012).
  • Standardized screening and follow-up: Implementing tools like the PHQ-9 for monitoring depression severity can help guide treatment decisions and ensure timely adjustments.
  • Education and decision support: Providing PCPs with continuing education on psychiatric prescribing and decision-support tools can enhance treatment precision.
  • Improved access to therapy: Expanding tele-therapy options and embedding behavioral health providers in primary care clinics can help bridge the gap between medication and psychotherapy.

Conclusion

Given the high volume of antidepressant prescriptions originating from primary care, ensuring optimal management is critical to improving patient outcomes. Strengthening collaboration between PCPs and mental health specialists, enhancing diagnostic accuracy, and integrating therapy referrals can help address current limitations.

Call to Action: If you are a healthcare professional involved in prescribing antidepressants, what strategies have you found effective in improving patient outcomes? Share your insights and experiences below.

What Happens When We Ignore Scientific Evidence?

When we reject the overwhelming scientific consensus that vaccines do not cause autism, we enter a dangerous world—one where facts are disregarded, misinformation thrives, and preventable diseases make a deadly comeback.

The Real Consequences of Vaccine Hesitancy

Vaccine hesitancy isn’t just a debate—it has real, measurable consequences

Measles Outbreaks: In early 2025, Texas experienced its most severe measles outbreak in nearly 30 years, with 198 confirmed cases as of March 7. The outbreak has resulted in 23 hospitalizations and one measles-related death—the first in the nation in a decade. The outbreak is primarily concentrated in rural Gaines County, where vaccination rates are notably low.

Whooping Cough Resurgence: Cases of pertussis (whooping cough) have increased in areas with lower vaccination rates, endangering infants who are too young to be fully vaccinated.

Polio’s Return: In 2022, a case of paralytic polio emerged in New York, decades after the disease had been eliminated in the U.S., traced back to vaccine hesitancy and low immunization coverage.

Ignoring evidence doesn’t just impact individuals—it threatens public health as a whole

Addressing Concerns: Why the Autism Myth Persists

Some parents worry about vaccine safety due to outdated or misleading claims, most notably a fraudulent 1998 study linking vaccines to autism. This study was retracted, and extensive research—including studies on hundreds of thousands of children—has confirmed no link between vaccines and autism. Yet, fear and misinformation persist, fueled by social media echo chambers and distrust in institutions.

While vaccine side effects do exist, they are typically mild (e.g., temporary soreness, fever) and far outweighed by the risks of the diseases they prevent. Scientific inquiry should always continue, but dismissing decades of rigorous research in favor of debunked myths endangers lives.

What Can We Do?

Combatting vaccine misinformation requires action. Here’s how you can help

✔ Speak Up: Correct misinformation when you see it, whether online or in conversations with friends and family.

✔ Rely on Experts: Trust reputable sources like the CDC, WHO, and medical professionals rather than social media influencers or unverified websites.

✔ Advocate for Science Education: Supporting critical thinking and scientific literacy helps build a society that values evidence over fear.

✔ Get Vaccinated: Lead by example—being up to date on vaccines protects you and those around you, especially vulnerable populations.

Science Is Not an Opinion

Truth is not subjective. If we abandon scientific evidence in favor of belief alone, we risk more than just vaccine-preventable diseases—we risk an era where facts no longer matter. The stakes are too high to let misinformation win.

Are all Delusions the Same Across Episodes of Psychosis?

As an inpatient psychiatrist, you encounter a wide array of stories and experiences. Many of my trainees find this to be the most fascinating and engaging part of the job. We have the unique opportunity to delve into the inner workings of the mind and understand the thought processes of patients with serious mental illnesses (SMI). One of the things that often emerges during our evaluations is the presence of various types of delusions. Some are more common than others, with persecutory and grandiose delusions being frequent examples. I often hear patients claim that unknown groups are conspiring to ruin their lives, or a manic patient might declare, “I’m Jesus Christ.”

Over the years, I’ve noticed that these delusions tend to remain consistent, with similar themes recurring during subsequent admissions. In case you’re wondering, I often see the same individuals with the same issues multiple times a year, giving me a wealth of data points to support this observation. This insight is supported by a recent article from JAMA Psychiatry, which found that delusional content remains consistent across episodes of psychosis. This consistency can help us recognize the early stages of decompensation and potentially intervene before hospitalization becomes necessary. For instance, if a patient claims, “I’m Jesus Christ” during one episode, it’s likely they will express the same delusion during future episodes.

Another significant finding from this study is the importance of maintaining the intensity of interventions throughout the follow-up period. Unfortunately, there are many reasons why this doesn’t always happen, but when it doesn’t, poor outcomes are often the result.

Link to the article: https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2821873?utm_source=twitter&utm_medium=social_jamapsyc&utm_term=14389007483&utm_campaign=top_viewed&linkId=549496680#:~:text=Meaning%20In%20this%20longitudinal%20observational,of%20interventions%20across%20the%20entire

Is ADHD A Real Psychiatric Disorder: This Will Blow Your Mind 

Introduction 

Attention deficit hyperactivity disorder (ADHD) in the adult population is a topic of great debate. There are many psychiatrists who say ADHD symptoms do not suddenly disappear as a person continues into adulthood. On the other hand, there are some psychiatrists who do not think ADHD is a real diagnosis. 

The term ADHD might be better thought of as attention deficit disorder (ADD). The concept of hyperactivity is more common in the child/adolescent patient population. It’s unclear if the hyperactivity is related to executive dysfunction which is the hallmark of ADHD. It may be that the hyperactivity is within the range of normal (agitation or activation) for a child, or signs of another mood disorder such as mania in bipolar illness (especially true in the adult population as bipolar diagnosis is commonly reserved for adult patients). 

We can make an argument that placing children in a traditional school setting where they are asked to sit and pay attention to uninteresting material for 7 hours is unnatural and directly against the way humans evolved to function. The human body and mind evolved to move and be active not to sit in classrooms. As a result, agitation, hyperactivity, and acting out can be the result of this unnatural state. 

The hallmark of ADHD is attentional impairment and executive dysfunction. Hyperactivity is not seen in adult populations with ADD. 

Attention As a Trait 

Attention can be thought of in the same manner as blood pressure. There is a mean blood pressure in the population but there will be individuals that fall outside the standard curve. Most people in the population will fall in the middle having a reasonable amount of attention and those with low attention levels do not necessarily have a disease although they may have consequences associated with reduced attentional activity. When someone is overly attentive it can be a symptom of disorders like obsessive compulsive disorder (OCD) or psychosis. Like blood pressure, having readings that are too high or too low can cause problems. It’s normal to have a certain amount of inattention, and we can think of attention as a spectrum with a range of normal levels. 

What are the Causes of Inattention 

-It could be a perfectly normal trait, as we explained some people have lower attention spans naturally as a personality trait 

-Mood disorders like depression and bipolar disorder have in inattention as a possible consequence of the change in mood 

-Psychotic disorders also have cognitive changes that may cause inattention (internal preoccupation) 

-Anxiety disorders 

-Neurocognitive disorders 

-We should avoid diagnosing ADD in the setting of one of these other conditions. 

Would you diagnosis ADD during a manic episode?

Prevalence of ADHD in the U.S. 

-The prevalence of ADHD in the U.S. ranges from 5.6% to 15.9% and there is great variability depending on the geographic region 

-For most biological diseases we should see similar prevalence rates across populations and geographic regions. For example, schizophrenia has a prevalence of about 1% worldwide. So why do we see significant differences across the U.S.? 

-We do not know much about the role socioeconomic factors, diet, exercise, and other social factors play in the development of ADHD. It’s possible that these are significant contributing factors resulting in the symptoms associated with ADHD. 

Is ADHD a neurodevelopmental issue? 

-One way of thinking about ADHD is as a neurodevelopmental problem that eventually improves over time. 

-In children with ADHD they seem to achieve peak cortical thickness later than children without ADHD, this has been confirmed on imaging studies. 

-The important part is eventually these children catch up with the normal controls. It’s more a delay in brain development and not a permanent state. 

-The ADHD children are about 2 years behind the normal controls and the area of greatest delay is the prefrontal cortex which is responsible for executive function. 

How Common is ADHD and Does it Last into Adulthood? 

Over the past decade ADHD in adult populations has gotten more attention. Some would say the prevalence in adults is 4% to 5% with equal rates being seen in men and women. 

The national comorbidity survey estimated 46% of children with ADHD have symptoms that persist into adulthood. Many of these individuals had comorbid anxiety disorders and we know anxiety can be a major cause of inattention and executive dysfunction. 

In other studies, similar findings were reported. What stands out to me in all these studies is the high rates of comorbid mood disorders including depression and bipolar disorder. It’s hard to make a diagnosis of adult ADHD in the presence of other conditions considering the significant overlap of symptoms and cognitive dysfunction associated with mood disorders. 

It’s possible that mood and anxiety disorder can account for most adult ADHD cases and a variation of a normal trait could explain the rest (individuals with low attention) 

Looking at medication response doesn’t help us much as amphetamines are helpful in everyone even those who do not have a psychiatric disorder (think college kids taking them for midterms) 

When you correct for comorbidities in Adult ADHD, only about half of the young adults meeting criteria for ADHD had ADHD only. Estimates from this showed that most children diagnosed with ADHD were no longer meeting criteria in adulthood (83% no longer had symptoms). Many of the newly diagnosed cases of ADHD were in individuals who did not have ADHD as children (87% did not have ADHD as children).  

This indicates that about 20% of children diagnosed with ADHD will have symptoms persist into adulthood, the other 80% will not 

In animal models, amphetamines have been shown to have some dangerous effects 

-Decrease response to reward stimuli 

-increased anxiety 

-decreased dopamine activity 

-decreased long-term survival of neuronal cell in the hippocampus (excitotoxicity) 

Risk of Substance Use With Stimulant Prescriptions

Most psychiatrists will tell you the risk of substance use disorder does not increase with stimulant medication treatment; in fact it’s reduced when ADHD is treated. However, a well-designed randomized controlled trial of delinquent behavior and emerging substance use in medication treated children found significantly higher rates of substance use in the stimulant treated individuals. The conclusion by Molina et al. was we need to re-evaluate the risk of substance use disorder as children age when they are prescribed stimulants. Now correlation does not equal causation, but this should give us some pause when blinding stating there is no risk for addiction with stimulant use (this claim is mostly based off observational data and not randomized controlled trial data). 

Introducing Shrinks In Sneakers on YouTube

I’ve done a soft rollout of the Shrinks In Sneakers YouTube channel over the past several months. I think I’m finally comfortable introducing it on the blog. I made the decision to start making videos because I can create content at a more rapid rate, and I can connect with the viewer in a more personal and intimate way. Please subscribe to the channel for updates. If you have specific topics you want covered, or have questions about existing content please comment. I will try to answer all questions and continue creating engaging content based on your interests. 

Cheers,

Dr. G

Link to YouTube Channel

https://www.youtube.com/channel/UCaaywi6nWB4zzpqBCMvxbsA

Powered by WordPress.com.

Up ↑